Navigation Links
NSBRI Funds Cerebrotech to Accelerate Development of Brain Monitoring Device
Date:3/12/2013

HOUSTON, March 12, 2013 /PRNewswire-USNewswire/ -- The National Space Biomedical Research Institute (NSBRI) announced today that Cerebrotech Medical Systems, Incorporated of Pleasanton, California is the recipient of the 2013 Space Medicine and Related Technologies Commercialization Assistance Program (SMARTCAP) award. Cerebrotech will receive a $250,000 grant to advance the development of its non-invasive portable monitor to detect changes in brain fluid levels. 

(Logo: http://photos.prnewswire.com/prnh/20130308/DC73596LOGO)

SMARTCAP is an openly solicited competitive program intended for small U.S. companies developing biomedical products that have the potential to safeguard the health of astronauts in space, as well as meet a medical need of patients on Earth. The program is managed and overseen by NSBRI's Industry Forum.

"By developing disruptive solutions for medical care in space, we are also impacting health care on Earth," said Dr. Dorit Donoviel , NSBRI Deputy Chief Scientist and Industry Forum Lead. "NSBRI's mission is to ensure astronaut health and use the knowledge and technologies developed for humans in space to improve life on Earth. The NSBRI Industry Forum engages the private sector to provide solutions for human spaceflight. Because a high bar is set for medical care in space, solutions developed for space generally possess unique features that translate to a competitive commercial advantage in terrestrial markets."

The SMARTCAP award is contingent on companies raising matched funding from a non-federal source, and is intended to position selected technologies for follow-on support from investors, potential industry partners or other funding entities.

Cerebrotech's magnetic induction phase-shift
'/>"/>

SOURCE National Space Biomedical Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
2. German Academic Exchange Service funds international project on spintronics
3. QB3-Industry Biotech Startup Partnership Funds Two Projects
4. Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial
5. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
6. VIC Investor Network to Significantly Accelerate Technology Company Growth
7. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
8. Nanofiber Production Device Set to Accelerate Research into Nanofiber Applications in Medicine
9. Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines
10. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
11. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , August 21, 2014 ... http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the addition of ...  report to their offering.       ... as hormone therapy, is a means of ... produced by the body. This type of ...
(Date:8/21/2014)... Mathematic studies at the Program for Evolutionary ... by the Jeffrey Epstein VI Foundation , have shown ... identified for elimination. These aggressive cells are the driver mutations ... topological map of what to look for when examining tumors, ... tumor cells can be extracted from biopsy, it,s very difficult ...
(Date:8/21/2014)... 21, 2014 Ontotext S4 , ... Ontotext . Now the same enterprise hardened ... structured and unstructured data is available to start-ups and ... enterprise technology. Organizations that do not have resources to ... can use S4 since there is no need for ...
(Date:8/20/2014)... patented university inventions licensed to biotechnology firms has ... To open these roadblocks, the researchers suggest that ... discovery stage could lead to faster commercialization down ... from discoveries made in university laboratories and licensed ... clinical trials, which have a high failure rate. ...
Breaking Biology Technology:Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... is its new technology. Much of the technology for the ... enable it to see farther back in time. As with ... used to benefit humankind in many other industries. The ... to the Hubble Space Telescope. The most powerful space telescope ...
... MILFORD, Mass., April 18, 2012 SeraCare Life Sciences, ... sciences company providing vital products and services to facilitate ... therapeutics, announced that, at a special meeting of shareholders ... agreement with Project Plasma Holdings Corporation and Project Plasma ...
... Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company ... therapeutic agents for the treatment of Alzheimer,s and ... into a collaboration agreement with the University California, ... acting peptide vaccine candidate to induce an immune ...
Cached Biology Technology:Webb Telescope spinoff technologies already seen in some industries 2Webb Telescope spinoff technologies already seen in some industries 3Webb Telescope spinoff technologies already seen in some industries 4SeraCare Shareholders Approve Acquisition by Linden Capital Partners 2SeraCare Shareholders Approve Acquisition by Linden Capital Partners 3Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimer's Research Group at University of California Irvine to Test First in Class Dual Target Vaccine 2Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimer's Research Group at University of California Irvine to Test First in Class Dual Target Vaccine 3Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimer's Research Group at University of California Irvine to Test First in Class Dual Target Vaccine 4
(Date:8/21/2014)... a significant reduction in smog-producing toxins in past ... A new study shows that while the Greater ... the toxins that contribute to smog, the city ... air pollution., Smog, which can cause or aggravate ... bronchitis, is produced by a set of complex ...
(Date:8/21/2014)... but they are the ultimate source of all organic ... dependent on algae, too, to suck up climate-warming carbon ... bottom of the ocean. Now, by using a combination ... showing that viruses infecting those algae are driving the ... else stays essentially the same, and this has important ...
(Date:8/21/2014)... researchers from Beth Israel Deaconess Medical Center (BIDMC ) ... Most Influential Scientific Minds 2014," a comprehensive list ... web resource for science metrics and research performance analysis. ... most influential "are performing and publishing work that their ... science," according to a Thomson Reuters statement. Researchers were ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Viruses take down massive algal blooms, with big implications for climate 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3
... vaccine for visceral leishmaniasis, a parasitic disease that kills ... issue of ACS Chemical Biology . Spread by ... infects about 500,000 people annually, with the majority of ... , Despite a major research thrust by the World ...
... for speech through in-utero eavesdropping, or is their penchant ... but one that's central to understanding the origins and ... McGill University psychologist believes she's separated out the complicating ... says Dr. Athena Vouloumanos, point to a genetic predilection ...
... there's no picture in this kind of article , ... key role in activating the Epstein Barr Virus in human ... Molecular Biology Laboratory (EMBL) and the Institut de Virologie Moléculaire ... the CNRS, in Grenoble. , Like Sleeping Beauty, the Epstein ...
Cached Biology News:Potential vaccine developed for deadly leishmaniasis disease 2Potential vaccine developed for deadly leishmaniasis disease 3Born with a love of speech 2Born with a love of speech 3Waking a sleeping virus 2
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
Request Info...
Biology Products: